Search research articles
Contact Us
Filters
Showing results (191-200 of 272) with videos related to
Page
of 28
Sort By:
Annals of Internal Medicine
|
July 1, 1981
VAB-6 combination chemotherapy in disseminated cancer of the testis
D Vugrin, H W Herr, W F Whitmore, et al.
AJR. American Journal of Roentgenology
|
August 1, 1997
CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria
S Hilton, H W Herr, J B Teitcher, et al.
Cancer Research
|
June 1, 1982
HLA antigens in patients with germ cell cancers of the testis
M S Pollack, D Vugrin, W Hennessy, et al.
The Journal of Urology
|
May 1, 1982
Flow cytometry of normal and nonneoplastic diseases of the bladder: an estimate of the false positive rate
F A Klein, H W Herr, P C Sogani, et al.
Cancer
|
August 1, 1982
Detection and follow-up of carcinoma of the urinary bladder by flow cytometry
F A Klein, H W Herr, P C Sogani, et al.
Urological Research
|
January 1, 1981
Androgen stimulated chemotherapy in the Dunning R-3327 prostatic adenocarcinoma
H B Grossman, E L Kleinert, M L Lesser, et al.
Cancer Research
|
October 1, 1984
Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice
H W Herr, E L Kleinert, P S Conti, et al.
The Journal of Urology
|
March 1, 1986
Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection
H W Herr, W F Whitmore, P C Sogani, et al.
National Cancer Institute Monograph
|
December 1, 1978
Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function
M A Bean, P S Schellhammer, H W Herr, et al.
The Journal of Urology
|
February 26, 1999
Can p53 help select patients with invasive bladder cancer for bladder preservation?
H W Herr, D F Bajorin, H I Scher, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 272) with videos related to
Sort By:
Page
of 28
Annals of Internal Medicine
|
July 1, 1981
VAB-6 combination chemotherapy in disseminated cancer of the testis
D Vugrin, H W Herr, W F Whitmore, et al.
AJR. American Journal of Roentgenology
|
August 1, 1997
CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria
S Hilton, H W Herr, J B Teitcher, et al.
Cancer Research
|
June 1, 1982
HLA antigens in patients with germ cell cancers of the testis
M S Pollack, D Vugrin, W Hennessy, et al.
The Journal of Urology
|
May 1, 1982
Flow cytometry of normal and nonneoplastic diseases of the bladder: an estimate of the false positive rate
F A Klein, H W Herr, P C Sogani, et al.
Cancer
|
August 1, 1982
Detection and follow-up of carcinoma of the urinary bladder by flow cytometry
F A Klein, H W Herr, P C Sogani, et al.
Urological Research
|
January 1, 1981
Androgen stimulated chemotherapy in the Dunning R-3327 prostatic adenocarcinoma
H B Grossman, E L Kleinert, M L Lesser, et al.
Cancer Research
|
October 1, 1984
Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice
H W Herr, E L Kleinert, P S Conti, et al.
The Journal of Urology
|
March 1, 1986
Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection
H W Herr, W F Whitmore, P C Sogani, et al.
National Cancer Institute Monograph
|
December 1, 1978
Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function
M A Bean, P S Schellhammer, H W Herr, et al.
The Journal of Urology
|
February 26, 1999
Can p53 help select patients with invasive bladder cancer for bladder preservation?
H W Herr, D F Bajorin, H I Scher, et al.
Page
of 28